* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Essentials of Glycobiology Lecture 42 June 9, 1998 Jeff Esko
Catalytic triad wikipedia , lookup
Drug discovery wikipedia , lookup
Amino acid synthesis wikipedia , lookup
Oligonucleotide synthesis wikipedia , lookup
Basal metabolic rate wikipedia , lookup
Biochemistry wikipedia , lookup
Evolution of metal ions in biological systems wikipedia , lookup
Nicotinamide adenine dinucleotide wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Adenosine triphosphate wikipedia , lookup
Fatty acid synthesis wikipedia , lookup
Butyric acid wikipedia , lookup
Specialized pro-resolving mediators wikipedia , lookup
Citric acid cycle wikipedia , lookup
MTOR inhibitors wikipedia , lookup
Development of analogs of thalidomide wikipedia , lookup
Enzyme inhibitor wikipedia , lookup
Discovery and development of neuraminidase inhibitors wikipedia , lookup
Essentials of Glycobiology Lecture 34 May 28, 2002 Jeff Esko Glycosylation Inhibitors Overview l l l l l l l Indirect inhibitors and metabolic poisons Tunicamycin - Inhibition of dolichol-PP-GlcNAc assembly Plant Alkaloids - Natural inhibitors of glycosidases Substrate analogs - Directed synthesis of inhibitors Glycoside primers - Mimicking what already works Inhibitors of glycolipids and GPI anchors Neuraminidase inhibitors - Rational design from Xray crystallography Introduction l Need to perturb structure to understand function l Inhibitors can lead to therapeutics Indirect Inhibitors and Metabolic Poisons In vitro inhibitors - nucleotide sugar analogs, acceptor analogs Sugar analogs - deoxyglucose, fluorinated sugars, mannosamine analogs Compounds that interfere with transport - Brefeldin A, ionophores, ammonium chloride Compounds that block intermediary metabolism - 6-diazo-5-oxo-L-norleucine (DON), chlorate Tunicamycin O HN O RCHN l Blocks the transfer of GlcNAc-1-P from UDPGlcNAc to dolichyl-P (GPT) l Resistant mutants overproduce GPT l Km for UDP-GlcNAc is ~3 x 10-6 M, whereas the Ki value for tunicamycin is ~5 x 10-8M OH HO O O O NHAc HO CH2 N O H H H OH H OH O OH HO OH Plant Alkaloids - Natural Inhibitors of Glycosidases a2 ± a3 a3 a3 a3 a2 a2 a2 a3 a3 a2 a2 a2 a6 a6 Asn a2 a2 a3 a3 b4 b4 a2 a2 a6 a6 b4 Asn a2 a3 a3 b4 a-glucosidase I a2 a6 a6 a3 b4 a-glucosidase II b4 Asn a3 a6 a6 b4 Asn Australine Kifunensin Deoxynojirimycin Castanospermine a3 b4 a-mannosidase I Deoxymannojirimycin a3 b2 a6 a3 a6 GlcNAc TI a6 b4 b4 a-mannosidase II b4 Asn b4 Asn Swainsonine Plant Alkaloids HO H OH CH2OH HO N OH H N OH OH HO N OH HO H C H 2OH OH Australine a-Glucosidase I N OH HO OH Castanospermine Deoxymannojirimycin a-Glucosidase I and II a-Mannosidase I l l Swainsonine a-Mannosidase II Alkaloids contain polyhydroxylated ring systems that mimic the orientation of hydroxyl groups in the natural substrates Protonation of the ring nitrogen may mimic the positive charge developed on the ring oxygen during the hydrolytic reaction Substrate Analogs - Directed Synthesis of Inhibitors l Modify the acceptor or nearby hydroxyl group in a substrate l Exhibit Ki values in the range of the Km for the parent substrate Hindgaul and coworkers Glycosidase Inhibitors l PUGNAC Galactonolactone l Many inhibitors of lysoomal and bacterial hydrolases are available Generally they mimic a proposed transition state since C1 takes on a trigonal orientation Synthetic Substrate Analogs Glycoside Primers - Substrate Mimicry l l l Prepare compounds that resemble biosynthetic HO intermediates HO Conjugate to a hydrophobic aglycone to enhance uptake and activity Alkylation or acylation also works H H O O H OH H H H H O OH O O O H O H O O H Sarkar et al (1995) Proc. Natl. Acad. Sci. USA 92: 3323 Xyloside Primers Block Proteoglycan Glycosylation Proteoglycan 6S 6S 6S 2S NS O NS 6S O NS NS 2 S 6S 6S O NS NS 2S Cell O 6S Xylose 6S Hydrophobic Aglycone O NS NS 2S Xyloside Fritz & Esko (2001) Methods Mol Biol. 171:309 Types of Primers OAc OAc OAc O O O AcO OAc Gal AcO O NHAc GlcNAc Naphthalene methanol Properties of Glycoside Primers l Priming usually exceeds normal levels of synthesis on endogenous conjugate l The enhanced rate of synthesis of oligosaccharides on primers may alter the assembly of other classes of glycoconjugates than those generated on the primer l Inhibition is rarely complete Properties of Glycoside Primers l Primers can reveal alternate glycosylation pathways l Primers represent starting points for making membrane permeable analogs that might have inhibitory activity without acting as a primer l Glycosides can be absorbed through the gut l Many glycosides occur naturally, especially in plants Natural Inhibitors of Glycosylation Alkaloids Flavonoids Carotenoids Steroids and others Glucosides Arabinosides Xylosides Ribosides Rhamnosides and others Natural Glycoside Primers Psittacanthus cucullaris 1 1 mg/ml 0.33 0.11 .037 .012 2 3 Alchornea triplinervia 4 1 2 3 Maieta guianensis 4 1 2 3 4 Plant extracts were prepared by graded solvent extraction (1-4) and assayed for GAG priming activity .004 0 Taylor et al. (1998) J. Biol. Chem. 273:22260 Natural GAG primers O 4" HO O 5" O 4" 2" O H 1" HO 3" HO 4 MeO O 6 1 7' O H O 3"' 5"' HO 4"' OH O Me OH 3,3'-Di-O-methyl ellagic acid4-O-b-D-xylopyranoside H 3 5 2 6 O 7' 1' O O 2' 6' 5' H O 7 1 OH 3' 4' 2"' 6"' 4 MeO 1"' O 2' 6' 5' 2" O H 1" O 7" C = O 7 1' O 3" H 5 3 2 5" 3' 4' OH OMe 2EAGX) 3,3'-Di-O-methyl ellagic acid 4-O-(3"-galloyl)-b-D-xylopyranoside Glycolysis Gal Glc ATP Fuc Man GlcNAc ATP ATP Pi Gal-1-P Glycogen Glc-6-P Fuc-1-P -NH3 Glutamine UTP UDP-Glc UDP-Gal Man-6-P Fru-6-P NAD UDP-Glc GlcN-6-P Glc-1-P Man-l-P AcCoA NAD+ GTP Dol-P ATP GDP-Man GlcNAc-6-P UDP-GlcA GTP Dol-P-Glc NADP -CO2 GlcNAc-l-P GalNAc GalNAc-1-P UTP GDP-Fuc UTP UDP-Xyl ATP Dol-P Dol-P-Man UDP-GalNAc UDP- GlcNAc ManNAc ATP CMP-Neu5Gc ManNAc-6-P PEP NADP CMP-Neu5Ac CTP Neu5Ac Neu5Ac-9-P Mannosamine derivatives (ManNR) can be used by this pathway Mannosamine Analogs Mahal et al. (1997) Science 276:1125 Metabolism of ManAzide results in display of cell surface azides. Reaction with exogenously delivered phosphine via the Staudinger ligation creates an amide-linked cell surface conjugate. Saxon & Bertozzi (2001) Annu. Rev. Cell Dev. Biol. 17:1 Inhibitors of Glycolipid Assembly Xylosides have a mild effect on glycolipid formation, due to the assembly of a GM3 like compound a3 b4 b -O-R b-O-Cer Glucosylceramide acts like a primer; an analog containing an exocyclic epoxide inhibits glycolipid formation (IC50 ~8 µM) b-O-Cer O Inhibitors of Glycolipid Assembly HO N-butyldeoxynojirimycin inhibits Glc-Cer synthesis CH2OH N HO HO The best inhibitors are analogs of the long chain base (sphingosine analogs) O N HO O N H DL-threo-PDMP Inhibitors of GPI anchors l l Mannosamine inhibits GPI anchor formation: ManNH2-Man-GlcN-PI is a poor substrate for the a2mannosyltransferase Trypanosomes selectively take up and exchange fatty acid analogs (10-(propoxy)decanoic acid) for acyl chains on glycosylphosphatidylinositol O O HO Neuraminidase Inhibitors l A neuraminidase inhibitor was deduced by assuming a carbocation arises at C1 in the transition state, which would cause C1 to adopt a trigonal (sp2) planar configuration Compounds mimicking this geometry had inhibitory activity (µM Ki value) Rational design from X-ray crystallography Potent Sialic Acid Analogs A sialic acid analog containing a positively charged guanidinium group instead of O4 had a Ki of 10-11 M due to an additional salt bridge Non-carbohydrate analogs based on of benzoic acid mimic the partially planar ring of the proposed intermediate OH OH HO O HNOCH3C H 2N C COOH CH2 NH NH 4-guanido-Neu5Ac-2-ene Therapeutics Relenza and Tamiflu are drugs based on these sialic acid analogs N-butylated alkaloids are under development as anti-viral and anti-tumor agents Other pharmaceutical applications of glycosylation and glycosidase inhibitors will be discussed later